Effects of Eugenol-Loaded Chitosan Biopolymer Nanoparticles on CYP51A and CYP51B Expression in Aspergillus fumigatus | ||
| Infection Epidemiology and Microbiology | ||
| Article 3, Volume 8, Issue 1, 2022, Pages 17-26 PDF (562.69 K) | ||
| Document Type: Original Research | ||
| DOI: 10.52547/iem.8.1.17 | ||
| Authors | ||
| Abozar Nasiri-Jahrodi1; Masoomeh Shams-Ghahfarokhi* 1; Mehdi Razzaghi Abyaneh2 | ||
| 1Department of Mycology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran 14115-331, Iran | ||
| 2Department of Mycology, Pasteur Institute of Iran, Tehran 13164, Iran | ||
| Abstract | ||
| Backgrounds: Aspergillus fumigatus is a pathogen responsible for invasive aspergillosis and the main leading cause of death in immunosuppressed individuals. The present study aimed to evaluate the impact of eugenol-loaded chitosan nanoparticles on the expression of CYP51a and CYP51b, two well-known genes responsible for triazole drug resistance in A. fumigatus. Materials & Methods: The minimum inhibitory concentration (MIC) of eugenol-loaded chitosan nanoparticles, chitosan, eugenol, and itraconazole was determined based on the Clinical and Laboratory Standards Institute M38-E3 method at concentrations of 4.6-2400, 11.7-12000, 2-2048, and 1-256 μg/mL, respectively. The expression of CYP51A and CYP51B was evaluated in A. fumigatus exposed to 0.5, 1, and 2× of MIC concentration of NPs and itraconazole using the real-time polymerase chain reaction. Findings: The obtained results showed that eugenol-loaded chitosan nanoparticles sucessfully reduced A. fumigatus fungal growth at 300 μg/mL concentration. MIC of chitosan, eugenol, and itraconazole was measured to be 6000, 256, and 4 μg/mL, respectively. The results of real-time PCR also revealed that eugenol-loaded chitosan nanoparticles increased the expression of both CYP51A and CYP51B in a dose-dependent manner. The expression of fungal CYP51A and CYP51B at mRNA level was significantly increased 1.26, 1.93, and 3.1-fold as well as 1.2, 2.1, and 2.4-fold at concentrations of 150, 300, and 600 μg/mL, respectively (p<.05). However, it seems that the prepared nanoparticles had a lower impact on the expression of these genes compared to itraconazole. Conclusion: Overall, these findings suggest that the treatment of A. fumigatus with eugenol-chitosan nanoparticles could increase the expression of the CYP51 gene, suggesting the anti-fungal property of these nanoparticles. | ||
| Keywords | ||
| Eugenol-loaded chitosan nanoparticle; Aspergillus fumigatus; CYP51A; CYP51B; Gene expression | ||
| References | ||
|
| ||
|
Statistics Article View: 159 PDF Download: 76 |
||
| Number of Journals | 45 |
| Number of Issues | 2,196 |
| Number of Articles | 24,877 |
| Article View | 28,768,057 |
| PDF Download | 18,603,216 |